Director John Owen Brennan resigns from ImmunityBio board

ImmunityBio, Inc.

John Owen Brennan resigned from the Board and all committees effective February 7, 2025.
Resignation was not due to any dispute with the Company regarding operations, policies, or practices.
Mr. Brennan had served as a director since 2021.
Company expressed appreciation for his service and contributions.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

John Owen Brennan

Director

IBRX · ImmunityBio, Inc.

Effective: 2025-02-07
Filed: February 7, 2025, 6:59 PM ET

On February 7, 2025, John Owen Brennan notified the Secretary of ImmunityBio, Inc., a Delaware corporation (the “Company”) of his resignation as a member of the Company’s Board of Directors (the “Board”) and from all committees of the Board on which he served, effective as of February 7, 2025.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

John Owen Brennan resigned as Director at ImmunityBio, Inc..

Action: resigned
Role: Director

Exact text from the filing

On February 7, 2025, John Owen Brennan notified the Secretary of ImmunityBio, Inc., a Delaware corporation (the “Company”) of his resignation as a member of the Company’s Board of Directors (the “Board”) and from all committees of the Board on which he served, effective as of February 7, 2025.

View on SEC.gov

ImmunityBio, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-25-022776

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.